Philip Tsai

Insider Reports History

Entity
Individual
Location
C/O Immunome, Inc., 18702 North Creek Parkway, Suite 100, Bothell, WA
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Tsai:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immunome Inc. Chief Technology Officer Common Stock 33.3K $280K $8.42 Mar 24, 2025 Direct
Immunome Inc. Chief Technology Officer Stock option (right to buy) 250K Jun 17, 2024 Direct

Insider Reports Filed by Philip Tsai

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMNM Immunome Inc. Mar 24, 2025 1 $104K 4 Mar 25, 2025 Chief Technology Officer
IMNM Immunome Inc. Nov 21, 2024 1 $198K 4 Nov 25, 2024 Chief Technology Officer
IMNM Immunome Inc. Jun 17, 2024 1 $0 4 Jun 18, 2024 Chief Technology Officer
IMNM Immunome Inc. Jun 17, 2024 0 $0 3 Jun 18, 2024 Chief Technology Officer